Newsroom

Sorted by: Latest

-

Epitech Group and Horus Pharma sign a global licensing agreement to develop adelmidrol in eye health

NICE, France--(BUSINESS WIRE)--Epitech Group S.p.A., an Italian biopharmaceutical firm specializing in neuro-inflammation, and Horus Pharma, a French laboratory specializing in ophthalmology, announce a global licensing agreement for adelmidrol, a molecule belonging to the ALIAmide family, developed by Epitech Group. This agreement grants Horus Pharma exclusive rights to develop and market adelmidrol for human ophthalmology and periocular dermatology applications. It aims to explore new approac...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-

Natixis Syndicate UK Regulatory Announcement:  Post-stabilisation Announcement

LONDON--(BUSINESS WIRE)--  Date: 20th November 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CNP Assurances Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 9th November 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of the Market Abuse Regulat...
-

Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3

LONDON--(BUSINESS WIRE)--  Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a) The naming of nominee or vehicle companies is insufficient. For...
-

Natixis Syndicate UK Regulatory Announcement: Post-Stabilisation Announcement

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 20th November 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. Pernod Ricard Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 21st October 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2...
-

Mechanics Bancorp Declares Fourth Quarter 2026 Cash Dividend

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Mechanics Bancorp (Nasdaq: MCHB) today announced that its Board of Directors has declared a cash dividend of $0.43 per share of Class A common stock and $4.30 per share of Class B common stock, each payable on December 10, 2026, to shareholders of record as of the close of business on November 30, 2026.About Mechanics BancorpMechanics Bancorp is headquartered in Walnut Creek, Calif., and is the financial holding company of Mechanics Bank, a full-service, FD...
-

Adyen Merchants Can Now Offer Klarna in AI Agent Checkout

NEW YORK--(BUSINESS WIRE)--Klarna (NYSE: KLAR), the everyday finance network, and Adyen (AMS: ADYEN) today announced that shoppers can now pay with Klarna when an AI agent checks out for them through Adyen Agentic. Klarna is the first payment option beyond cards available in Adyen Agentic, Adyen’s agentic commerce suite, and merchants that already offer Klarna through Adyen can switch it on with no new integration work. Today, most AI shopping agents complete purchases with a stored credit or d...
-

MicroAge Elevates Industry Veteran Tracey Hayes to President

GREENVILLE, SC--(BUSINESS WIRE)--ScanSource, Inc. (NASDAQ: SCSC), a leading technology distributor uniquely positioned to address complex technologies, today announced the appointment of Tracey Hayes to president of MicroAge, effective January 1, 2027. As president, Hayes will be responsible for leading the organization’s strategic vision and supporting its long-term growth, ensuring the delivery of innovative cybersecurity, modern infrastructure, AI and cloud solutions, and managed services to...
-

The ONE Group Accelerates Growth of Benihana Express with Launch of National Licensing Program

DENVER--(BUSINESS WIRE)--The ONE Group Hospitality, Inc. (“The ONE Group” or the “Company”) (Nasdaq: STKS) today announced the launch of a licensing program for Benihana Express, its premium fast-casual concept that brings the iconic flavors and culinary heritage of Benihana to a convenient, contemporary dining format. Designed for flexibility, operational simplicity and scalability, Benihana Express creates new opportunities for experienced operators and developers to introduce one of America’...
-

Savara Informed That FDA Will Not Take Action on the Molgramostim BLA for Autoimmune Pulmonary Alveolar Proteinosis (Autoimmune PAP) by the PDUFA Date

YARDLEY, Pa.--(BUSINESS WIRE)--Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company focused on rare respiratory diseases, today announced that the U.S. Food and Drug Administration (FDA) has communicated that it will not meet the Prescription Drug User Fee Act (PDUFA) target action date of November 22, 2026 for the Company’s molgramostim inhalation solution (molgramostim) Biologics License Application (BLA) for the treatment of autoimmune PAP. The review of the BLA is ongoing...